文献速递腹部CT

改良美国国家综合癌症网络标准评估胰腺导管腺癌可切除性

Modified National Comprehensive Cancer Network Criteria for Assessing Resectability of Pancreatic Ductal Adenocarcinoma.
PubMed 文献 · AJR Am J Roentgenol · 2018-04-09

研究纳入86例连续胰腺导管腺癌患者,行动态增强CT,分别按NCCN指南、日本胰腺学会(JPS)一般规则及两者联合评分评估可切除性。联合评分区分R0与R1/R2的AUC为0.874,显著高于NCCN评分的0.725(p=0.0059),提示联合标准优于单一标准。

要点

  • 联合评分区分R0与R1/R2的AUC为0.874,高于NCCN评分的0.725(p=0.0059)。
  • NCCN评分敏感度100.0%、特异度40.0%;JPS评分敏感度63.9%、特异度84.0%。
  • 联合评分敏感度86.9%、特异度68.0%,优于NCCN评分单独评估。

核心结论

  • 基于NCCN指南与JPS一般规则联合标准评估PDAC可切除性优于任一单独标准。

研究设计与样本

  • 回顾性分析86例连续PDAC患者(男50例、女36例,平均年龄70.8±9.0岁,范围49-86岁),行动态增强CT,以组织病理学或术中发现为参考标准。

关键影像表现/征象

  • 按NCCN指南评估血管侵犯程度:无血管侵犯0分,肿瘤接触≤180°为1分,接触>180°为2分。
  • 按JPS一般规则评估直接侵犯邻近结构:无侵犯0分,有侵犯1分。
  • NCCN评分与JPS评分之和为联合评分。

诊断标准与关键数值

  • NCCN评分区分R0与R1/R2的敏感度100.0%、特异度40.0%、AUC 0.725。
  • JPS评分区分R0与R1/R2的敏感度63.9%、特异度84.0%、AUC 0.824。
  • 联合评分区分R0与R1/R2的敏感度86.9%、特异度68.0%、AUC 0.874。
  • 联合评分AUC显著大于NCCN评分(p=0.0059)。

临床应用与阅片要点

  • 联合NCCN血管侵犯评分与JPS邻近结构侵犯评分可能提高PDAC可切除性评估的区分能力。
  • NCCN评分敏感度高(100.0%)但特异度低(40.0%),JPS评分特异度较高(84.0%)但敏感度较低(63.9%)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The objective of our study was to assess the preoperative resectability of pancreatic ductal adenocarcinoma (PDAC) using the National Comprehensive Cancer Network (NCCN) guideline, the general rules of the Japan Pancreas Society (JPS), and both of them combined.

MATERIALS AND METHODS: Eighty-six consecutive patients with PDAC (50 men and 36 women; mean age ± SD, 70.8 ± 9.0 years; age range, 49-86 years) underwent dynamic contrast-enhanced CT. Following the NCCN guideline, the degree of vascular invasion was evaluated to determine the NCCN score: 0 points for absence of vascular invasion, 1 point for tumor contact ≤ 180°, and 2 points for tumor contact > 180°. Direct invasion to adjacent structures was rated according to the general rules of JPS to determine the JPS score: 0 points for absence and 1 point for presence. The NCCN score, JPS score, and sum of the two scores, which we refer to as the "combined score," were compared with histopathologic or intraoperative findings as well as for the differentiation of R0 resection (negative resection margins) from R1 (microscopic tumor infiltration) and R2 (macroscopic residual tumor) using ROC curve analysis.

RESULTS: The sensitivities, specificities, and areas under the ROC curves (AUCs) for the differentiation of R0 from R1 and R2 were 100.0%, 40.0%, and 0.725, respectively, with the NCCN score; 63.9%, 84.0%, and 0.824 with the JPS score; and 86.9%, 68.0%, and 0.874 with the combined score. The AUC of the combined score was significantly greater than that of the NCCN score (p = 0.0059).

CONCLUSION: The assessment of resectability of PDAC based on the combined criteria of the NCCN guideline and general rules of JPS was superior to that based on either criterion alone.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Noda Y, Goshima S, Kawada H, et al. Modified National Comprehensive Cancer Network Criteria for Assessing Resectability of Pancreatic Ductal Adenocarcinoma. AJR Am J Roentgenol. 2018. PMID: 29629801. doi:10.2214/AJR.17.18595

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。